Key industry and government regulations provide a cybersecurity foundation in advanced therapies
Pharmaceutical and biotech companies suffer more security breaches than any other industry1 — with greater than 20% of companies in the pharmaceutical sector having been…
Cybersecurity success in advanced therapies starts by prioritizing security as a “Way of working”
Pharmaceutical and biotech companies suffer more security breaches than any other industry1 — with greater than 20% of companies in the pharmaceutical sector having been…
Cybersecurity challenges in advanced therapies — introducing five strategies for success
Pharmaceutical and biotech companies suffer more security breaches than any other industry1 — with greater than 20% of companies in the pharmaceutical sector having been…
Lykan Bioscience and Vineti Announce Partnership to Advance Cell-based Therapies from Clinical to Commercialization
Lykan Bioscience’s world-class manufacturing capabilities, integrated with Vineti’s leading digital enterprise platform for cell and gene therapy supply chains, will streamline process development and manufacturing…
Vineti announces agreement with Imvax to utilize Vineti’s PTM Essentials™ solution
Vineti’s enterprise technology will enable critical patient-specific Chain of Custody management for Imvax, supporting Imvax’s goal of reaching more patients as fast as possible